prof. Petra Schelstraete
- ORCID iD
-
0000-0002-9560-8275
Show
Sort by
-
Shifts in systemic inflammatory profiles on elexacaftor/tezacaftor/ivacaftor predict clinical outcomes in cystic fibrosis
-
Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations
-
Impact of reporting rapid susceptibility results in Gram negative bloodstream infections : a real world prospective study
-
- Journal Article
- A1
- open access
The use of information technology to improve interdisciplinary communication during infectious diseases ward rounds on the paediatric intensive care unit
-
‘Let’s START TO TDM’ : advancing a pharmacy-led therapeutic drug monitoring advisory service within an antimicrobial stewardship program
-
Evaluation and expansion of a pharmacy-led therapeutic drug monitoring advisory service as part of an antimicrobial stewardship programme
-
Expansion of MALDI-TOF MS database as a strategy for identification of Haemophilus species other than H. influenzae
-
- Journal Article
- A1
- open access
Spiroplasma infection as a cause of severe congenital keratouveitis, cataract and glaucoma
-
The hyperPed-COVID international registry : impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C
-
SARS-CoV-2 infection in children less than forty days hospitalized in Belgium between 2020 and 2022